TS621257798	drug 69 89	INCB018424 phosphate
TS1421257798	drug 114 134	INCB018424 phosphate
TS1321257798	drug 139 170	potent inhibitor of JAK enzymes
TS721257798	treatedDisease 246 259	myelofibrosis
TS1221257798	food 557 561	food
TS221257798	drugEffect 776 791	bioavailability
TS321257798	mealTime 1015 1030	A high-fat meal
TS821257798	drug 1092 1102	INCB018424
TS521257798	drugEffect 1289 1309	cytokine stimulation
T1	modeadm 56 62	orally
T2	drugEffect 176 204	selectivity for JAK1sentand2
R1	treat Arg1:TS1421257798 Arg2:TS721257798	
R2	treat Arg1:TS1321257798 Arg2:TS721257798	
T3	treatedDisease 262 264	MF
T4	modeadm 273 277	oral
T5	drug 350 360	INCB018424
T6	dosage 516 527	5 to 200 mg
T7	drug 528 538	INCB018424
T8	frequency 641 662	once- and twice-daily
T9	duration 670 681	for 10 days
T10	drug 745 755	INCB018424
T11	drug 835 845	INCB018424
T12	modeadm 857 861	oral
T13	drug 1039 1049	INCB018424
R3	decrease_absorption Arg1:TS321257798 Arg2:T13	
R4	no_effect_on_drug Arg1:TS321257798 Arg2:TS821257798	
T14	drug 1214 1224	INCB018424
T15	drug 1109 1119	INCB018424
T16	drugEffect 1244 1278	inhibition of phosphorylated STAT3
R5	has_effect Arg1:T14 Arg2:T16	
R6	has_effect Arg1:T14 Arg2:TS521257798	
T17	drug 1356 1366	INCB018424
T18	drug 1391 1401	INCB018424
T19	dosage 1447 1452	25 mg
T20	frequency 1453 1456	bid
T21	dosage 1461 1467	100 mg
T22	frequency 1468 1470	qd
